Stockscreener 앱 받기
9.25
1.98%
0.18
Optimizerx Corp 주식(OPRX)의 최신 뉴스
One manager reports sole voting power over 1.32M OptimizeRx (OPRX) shares held by clients. - Stock Titan
Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Canada
Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com UK
Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each. - Stock Titan
Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Nigeria
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? - Zacks Investment Research
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath - Stock Titan
Optimizerx stock edges lower as investors digest recent results - AD HOC NEWS
OptimizeRx stock gains guidance clarity after Q2 2026 results - AD HOC NEWS
OPRX 8-K FilingsOptimizeRx Corporation SEC 8-K - Stock Titan
OptimizeRx CorporationCommon Stock (Nasdaq:OPRX) Detailed Stock Data - The Chronicle-Journal
OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.com.au
One prompt now builds patient and doctor audiences. OptimizeRx expanded the tool. - Stock Titan
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - marketscreener.com
A 10th annual growth conference is set for New York, with OptimizeRx taking part. - Stock Titan
OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.ca
OptimizeRx (OPRX) insider stock withheld for taxes - Stock Titan
OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com Canada
OptimizeRx appoints Troy Sarich as company advisor - investing.com
OptimizeRx Appoints Former Johnson & Johnson Executive Troy Sarich as Company Advisor - Quiver Quantitative
OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com UK
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor - Yahoo Finance UK
OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding - Stock Titan
OptimizeRx (OPRX) records insider share trade - Stock Titan
OptimizeRx (NASDAQ: OPRX) insider logs new stock trade - Stock Titan
OptimizeRx (NASDAQ: OPRX) reports new insider share transaction - stocktitan.net
OPRX | OptimizeRx Corporation Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript - AOL.com
OptimizeRx (OPRX) EPS and Revenue: Profit Per Share Clears Its Benchmark in the Current Update; Closing Move - vinanet.vn
OptimizeRx Corp (OPRX) Stock News Today - TradingKey
OptimizeRx Corp (OPRX) Stock News Today - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
OptimizeRx (OPRX) Slips to $8.72 as Shares Consolidate Near Range MidpointInverse ETF Flow - vinanet.vn
Optimizerx Stock Price Forecast. Should You Buy OPRX? - StockInvest.us
OptimizeRx Corp (OPRX) gains 6.7% institutional holder in Kennedy Capital - Stock Titan
Conferencia de resultados del segundo trimestre fiscal de 2026 de OptimizeRx (OPRX): Reitera previsiones mientras los ingresos caen un 30% - TradingKey
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - marketbeat.com
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com Nigeria
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com South Africa
Citizens raises OptimizeRx stock price target on macro stability - Investing.com
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com Canada
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com India
Citizens raises OptimizeRx stock price target on macro stability - Investing.com
Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX) Earnings Call zu Q2 des Geschäftsjahres 2026: Prognose bestätigt, während der Umsatz um 30 % sinkt - TradingKey
OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30% - TradingKey
Stifel cuts OptimizeRx stock price target on revenue headwinds By Investing.com - Investing.com Australia
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline - The Globe and Mail
OptimizeRx (OPRX) revenue falls 21% as margins and cash flow hold - Stock Titan
0.24%
0.00%
자본화:
|
볼륨(24시간):